Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 7
2003 5
2004 5
2005 8
2006 14
2007 8
2008 4
2009 19
2010 13
2011 7
2012 18
2013 15
2014 14
2015 14
2016 14
2017 10
2018 7
2019 11
2020 12
2021 12
2022 14
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

213 results

Results by year

Filters applied: . Clear all
Page 1
Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma.
Mateos MV, Dimopoulos MA, Cavo M, Suzuki K, Jakubowiak A, Knop S, Doyen C, Lucio P, Nagy Z, Kaplan P, Pour L, Cook M, Grosicki S, Crepaldi A, Liberati AM, Campbell P, Shelekhova T, Yoon SS, Iosava G, Fujisaki T, Garg M, Chiu C, Wang J, Carson R, Crist W, Deraedt W, Nguyen H, Qi M, San-Miguel J; ALCYONE Trial Investigators. Mateos MV, et al. N Engl J Med. 2018 Feb 8;378(6):518-528. doi: 10.1056/NEJMoa1714678. Epub 2017 Dec 12. N Engl J Med. 2018. PMID: 29231133 Free article. Clinical Trial.
Safety and clinical efficacy of BCMA CAR-T-cell therapy in multiple myeloma.
Roex G, Timmers M, Wouters K, Campillo-Davo D, Flumens D, Schroyens W, Chu Y, Berneman ZN, Lion E, Luo F, Anguille S. Roex G, et al. Among authors: berneman zn. J Hematol Oncol. 2020 Dec 3;13(1):164. doi: 10.1186/s13045-020-01001-1. J Hematol Oncol. 2020. PMID: 33272302 Free PMC article.
10-day decitabine versus 3 + 7 chemotherapy followed by allografting in older patients with acute myeloid leukaemia: an open-label, randomised, controlled, phase 3 trial.
Lübbert M, Wijermans PW, Kicinski M, Chantepie S, Van der Velden WJFM, Noppeney R, Griškevičius L, Neubauer A, Crysandt M, Vrhovac R, Luppi M, Fuhrmann S, Audisio E, Candoni A, Legrand O, Foà R, Gaidano G, van Lammeren-Venema D, Posthuma EFM, Hoogendoorn M, Giraut A, Stevens-Kroef M, Jansen JH, de Graaf AO, Efficace F, Ammatuna E, Vilque JP, Wäsch R, Becker H, Blijlevens N, Dührsen U, Baron F, Suciu S, Amadori S, Venditti A, Huls G; EORTC Leukemia Group, GIMEMA, and German MDS Study Group. Lübbert M, et al. Lancet Haematol. 2023 Nov;10(11):e879-e889. doi: 10.1016/S2352-3026(23)00273-9. Lancet Haematol. 2023. PMID: 37914482 Free article. Clinical Trial.
Dendritic Cell-Based Immunotherapy of Acute Myeloid Leukemia.
Van Acker HH, Versteven M, Lichtenegger FS, Roex G, Campillo-Davo D, Lion E, Subklewe M, Van Tendeloo VF, Berneman ZN, Anguille S. Van Acker HH, et al. Among authors: berneman zn. J Clin Med. 2019 Apr 27;8(5):579. doi: 10.3390/jcm8050579. J Clin Med. 2019. PMID: 31035598 Free PMC article. Review.
Cefepime and mortality.
Mebis J, Goossens H, Berneman ZN. Mebis J, et al. Among authors: berneman zn. Lancet Infect Dis. 2009 Oct;9(10):585-6. doi: 10.1016/S1473-3099(09)70238-5. Lancet Infect Dis. 2009. PMID: 19778758 No abstract available.
Neuroendocrine immunoregulation in multiple sclerosis.
Deckx N, Lee WP, Berneman ZN, Cools N. Deckx N, et al. Among authors: berneman zn. Clin Dev Immunol. 2013;2013:705232. doi: 10.1155/2013/705232. Epub 2013 Dec 8. Clin Dev Immunol. 2013. PMID: 24382974 Free PMC article. Review.
SARS-CoV-2 and cancer: Are they really partners in crime?
van Dam PA, Huizing M, Mestach G, Dierckxsens S, Tjalma W, Trinh XB, Papadimitriou K, Altintas S, Vermorken J, Vulsteke C, Janssens A, Berneman Z, Prenen H, Meuris L, Vanden Berghe W, Smits E, Peeters M. van Dam PA, et al. Among authors: berneman z. Cancer Treat Rev. 2020 Sep;89:102068. doi: 10.1016/j.ctrv.2020.102068. Epub 2020 Jul 11. Cancer Treat Rev. 2020. PMID: 32731090 Free PMC article. Review.
Gilteritinib as Post-Transplant Maintenance for Acute Myeloid Leukemia With Internal Tandem Duplication Mutation of FLT3.
Levis MJ, Hamadani M, Logan B, Jones RJ, Singh AK, Litzow M, Wingard JR, Papadopoulos EB, Perl AE, Soiffer RJ, Ustun C, Ueda Oshima M, Uy GL, Waller EK, Vasu S, Solh M, Mishra A, Muffly L, Kim HJ, Mikesch JH, Najima Y, Onozawa M, Thomson K, Nagler A, Wei AH, Marcucci G, Geller NL, Hasabou N, Delgado D, Rosales M, Hill J, Gill SC, Nuthethi R, King D, Wittsack H, Mendizabal A, Devine SM, Horowitz MM, Chen YB; BMT-CTN 1506/MORPHO Study Investigators. Levis MJ, et al. J Clin Oncol. 2024 Mar 12:JCO2302474. doi: 10.1200/JCO.23.02474. Online ahead of print. J Clin Oncol. 2024. PMID: 38471061
mRNA electroporation as a tool for immunomonitoring.
Cools N, Van Camp K, Van Tendeloo V, Berneman Z. Cools N, et al. Among authors: berneman z. Methods Mol Biol. 2013;969:293-303. doi: 10.1007/978-1-62703-260-5_18. Methods Mol Biol. 2013. PMID: 23296941 Review.
Cell cycle and apoptosis.
Vermeulen K, Berneman ZN, Van Bockstaele DR. Vermeulen K, et al. Among authors: berneman zn. Cell Prolif. 2003 Jun;36(3):165-75. doi: 10.1046/j.1365-2184.2003.00267.x. Cell Prolif. 2003. PMID: 12814432 Free PMC article. Review.
213 results